Skip to content
value.today

Provisio Medical, Inc.

Total raised
$31 M
6 rounds on record
Latest round
$5 M
Jun 2024
First round on record
Sep 2016
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Provisio Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2024$5 MNo. 6$2 to $10 million

Provisio Medical, Inc.: Raise no. 6, Jun 2024

Investors in this round

28 investors had bought by the notice of Jul 3, 2024: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $15 M offered; $10 M still to sell
Smallest investment taken
$50,000
What was sold
equity, debt, other: Units of Series B Debentures and Warrants
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • John J. Blake · Executive Officer
  • Stephen Eric Ryan · Executive Officer, Director, Promoter
  • Aurelio Eric Fernandez · Director
  • Frank J. Del Rio · Director
  • John J. McCallum · Director
  • Michael J. Chobotov · Director
  • Timothy Eric Lindenfelser · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On fees: “Broker may also receive warrant compensation equal to 1% (up to 3%) of the Gross Proceeds sold by said broker. Term of five years, cashless exercise option, convertible into common shares, and exercise price = $3.91 per share.”

Signed by Stephen Eric Ryan, President. Source: SEC Form D, newest notice filed Jul 3, 2024. Read the notice at the SEC.

equity, debtSEC
Apr 2023$5 MNo. 5$2 to $10 million

Provisio Medical, Inc.: Raise no. 5, Apr 2023

Investors in this round

19 investors had bought by the notice of Apr 7, 2023: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $25 M offered; $20 M still to sell
Smallest investment taken
$100,000
What was sold
equity, other: Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$115,500
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • John J. Blake · Executive Officer
  • Stephen Eric Ryan · Executive Officer, Director, Promoter
  • Aurelio Eric Fernandez · Director
  • Frank J. Del Rio · Director
  • John J. McCallum · Director
  • Michael J. Chobotov · Director
  • Timothy Eric Lindenfelser · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • LifeSci Capital (CRD 168404) · broker-dealer LifeSci Capital (CRD 168404) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “Broker also to receive warrant compensation = equity warrants equal to 1% of the Gross Proceeds sold by said broker. Term of five years, cashless exercise option, convertible into common shares, and exercise price = 125% of the price per share paid by in”

Signed by Stephen Eric Ryan, President. Source: SEC Form D, newest notice filed Apr 7, 2023. Read the notice at the SEC.

equitySEC
Nov 2022$11 MNo. 4$10 to $50 million

Provisio Medical, Inc.: Raise no. 4, Nov 2022

Investors in this round

53 investors had bought by the notice of Nov 25, 2022: 53 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $30 M offered; $19 M still to sell
Smallest investment taken
$100,000
What was sold
equity, other: Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$115,500
Finders' fees
none
Paid to its own people
$500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • John J. Blake · Executive Officer
  • Stephen Eric Ryan · Executive Officer, Director, Promoter
  • Aurelio Eric Fernandez · Director
  • Frank J. Del Rio · Director
  • John J. McCallum · Director
  • Michael J. Chobotov · Director
  • Timothy Eric Lindenfelser · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • LifeSci Capital (CRD 168404) · broker-dealer LifeSci Capital (CRD 168404) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “Broker also to receive warrant compensation = equity warrants equal to 1% of the Gross Proceeds sold by said broker. Term of five years, cashless exercise option, convertible into common shares, and exercise price = 125% of the price per share paid by in”

Signed by Stephen Eric Ryan, President. Source: SEC Form D, newest notice filed Nov 25, 2022. Read the notice at the SEC.

equitySEC
Jan 2021$4 MNo. 3$2 to $10 million

Provisio Medical, Inc.: Raise no. 3, Jan 2021

Investors in this round

16 investors had bought by the notice of Jun 4, 2021: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$50,000
What was sold
equity, other: Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$400,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Eric Ryan · Executive Officer, Director, Promoter
  • Aurelio Eric Fernandez · Director
  • Frank J. Del Rio · Director
  • George J. Quinoy · Director
  • Timothy Eric Lindenfelser · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Eric Ryan, President. Source: SEC Form D and 1 amendment, newest notice filed Jun 4, 2021. Read the notice at the SEC.

equitySEC
Aug 2019$5 MNo. 2$2 to $10 million

Provisio Medical, Inc.: Raise no. 2, Aug 2019

Investors in this round

24 investors had bought by the notice of Jul 23, 2020: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$50,000
What was sold
equity, other: Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$700,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Eric Ryan · Executive Officer, Director, Promoter
  • Aurelio Eric Fernandez · Director
  • George Eric Quinoy · Director
  • Kenneth Eric McDonnell · Director
  • Timothy Eric Lindenfelser · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Eric Ryan, President. Source: SEC Form D and 3 amendments, newest notice filed Jul 23, 2020. Read the notice at the SEC.

equitySEC
Sep 2016$1 MNo. 1Under $2 million

Provisio Medical, Inc.: Raise no. 1, Sep 2016

Investors in this round

10 investors had bought by the notice of May 17, 2017: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
$25,000
What was sold
equity, other: Preferred Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$175,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Eric Ryan · Executive Officer, Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Eric Ryan, President. Source: SEC Form D, newest notice filed May 17, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Provisio Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2024).

    SEC Form D · Jul 2024

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Jul 2024

That is all the official record says: Provisio Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Provisio Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 53 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Provisio Medical, Inc.
NameRoleNamed in
John J. BlakeExecutive officerJul 2024
Stephen Eric RyanExecutive officerJul 2024
Aurelio Eric FernandezDirectorJul 2024
Frank J. Del RioDirectorJul 2024
John J. McCallumDirectorJul 2024
Michael J. ChobotovDirectorJul 2024
Stephen Eric RyanDirectorJul 2024
Timothy Eric LindenfelserDirectorJul 2024
George J. QuinoyDirectorJun 2021
George Eric QuinoyDirectorJul 2020
Kenneth Eric McDonnellDirectorJul 2020
Stephen Eric RyanPromoterJul 2024